NCT03719495View on ClinicalTrials.gov

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

CompletedOBSERVATIONAL

Enrollment

68

Participants

Timeline

Start Date

June 19, 2019

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions

Breast CancerEstrogen Receptor-positive Breast CancerHealthy

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Duke University

OTHER

NCT03719495 - Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter